Over-expression of miR-31 or loss of KCNMA1 leads to increased cisplatin resistance in ovarian cancer cells.
about
MicroRNAs, DNA Damage Response, and Cancer TreatmentCirculating miR-31 as an effective biomarker for detection and prognosis of human cancer: a meta-analysis.Failure of Elevating Calcium Induces Oxidative Stress Tolerance and Imparts Cisplatin Resistance in Ovarian Cancer Cells.Comprehensive analysis of lncRNA expression profiles reveals a novel lncRNA signature to discriminate nonequivalent outcomes in patients with ovarian cancer.KCNN4 and S100A14 act as predictors of recurrence in optimally debulked patients with serous ovarian cancer.MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.RNA-based ovarian cancer research from 'a gene to systems biomedicine' perspective.Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance.miRNAs and ovarian cancer: a miRiad of mechanisms to induce cisplatin drug resistance.MicroRNA-20a contributes to cisplatin-resistance and migration of OVCAR3 ovarian cancer cell line.MicroRNA-184 Modulates Doxorubicin Resistance in Osteosarcoma Cells by Targeting BCL2L1.The Diagnostic and Prognostic Potential of microRNAs in Epithelial Ovarian Carcinoma.MicroRNAs in gynecological cancers: Small molecules with big implications.Extracellular vesicles released following heat stress induce bystander effect in unstressed populationsThe combined activation of KCa3.1 and inhibition of Kv11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells.Cisplatin induces the release of extracellular vesicles from ovarian cancer cells that can induce invasiveness and drug resistance in bystander cells.Downregulation of miR-503 contributes to the development of drug resistance in ovarian cancer by targeting PI3K p85.Transcriptional Repression and Protein Degradation of the Ca2+-Activated K+ Channel KCa1.1 by Androgen Receptor Inhibition in Human Breast Cancer Cells.Identification of core aberrantly expressed microRNAs in serous ovarian carcinoma.
P2860
Q28067062-757943AF-6F6C-4839-9198-945614823E7EQ33709838-FF832AFD-1B56-4376-A3FD-F6B5FBC0A487Q36983497-8CA7B034-BB8B-4BD0-A0DC-944CDD7D763AQ37362685-00E3970A-4725-45C7-AEF1-B69F86BB243FQ37536735-8FA0C710-ACF9-4712-B85D-36C92B86E754Q37696266-E26D43CA-7B24-4AFF-8D6F-10E6F4C5B3B6Q38432883-66228BA8-7FC4-4196-9975-5084B653ED38Q38546133-9A70AB2F-6417-41C8-99C5-A7425D46F193Q38633144-324FCB22-3568-4BC8-A0A7-201D24931FC9Q38695476-6933AC7F-DFED-4AB5-9269-AC80DC57235CQ38768632-154B0DAC-E171-4868-AFE1-777591376BDAQ38975570-733620ED-E6DD-4557-9DD3-A9C6FA4F410DQ39333266-1D3AD698-DEB7-4FBC-A8D3-BB9679C2009EQ40980069-5458A6F1-0BC2-4DDB-9973-E661EA227FF2Q46097844-B06C792B-858A-4DB8-8097-41DE9EE5F6DFQ46538048-D15C7157-2F4C-46FA-8600-DF5189AD3C98Q48256677-662C74F3-668B-4D50-B913-2FB09DA7D840Q52715350-A69DA7FA-9D61-4205-8623-92F17977BAB8Q54962236-7D0FA6A3-ADCD-4863-8993-0EFDA1C70552
P2860
Over-expression of miR-31 or loss of KCNMA1 leads to increased cisplatin resistance in ovarian cancer cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Over-expression of miR-31 or l ...... tance in ovarian cancer cells.
@en
type
label
Over-expression of miR-31 or l ...... tance in ovarian cancer cells.
@en
prefLabel
Over-expression of miR-31 or l ...... tance in ovarian cancer cells.
@en
P2093
P2860
P50
P1433
P1476
Over-expression of miR-31 or l ...... stance in ovarian cancer cells
@en
P2093
Daniel Paul Caley
David Raul Francisco Carter
James Michael Stevenson Currie
Susan Ann Brooks
P2860
P2888
P304
P356
10.1007/S13277-015-4081-Z
P577
2015-09-19T00:00:00Z
P5875
P6179
1006294121